Addex Therapeutics Ltd ADXN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 4:00 PM EDT
9.31quote price arrow down-0.03 (-0.32%)
Volume
2,263
52 week range
5.00 - 27.90
Loading...
  • Open9.57
  • Day High9.57
  • Day Low9.33
  • Prev Close9.34
  • 52 Week High27.90
  • 52 Week High Date04/09/24
  • 52 Week Low5.00
  • 52 Week Low Date12/15/23

Key Stats

  • Market Cap14.303M
  • Shares Out1.54M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta1.80
  • YTD % Change54.22

KEY STATS

  • Open9.57
  • Day High9.57
  • Day Low9.33
  • Prev Close9.34
  • 52 Week High27.90
  • 52 Week High Date04/09/24
  • 52 Week Low5.00
  • 52 Week Low Date12/15/23
  • Market Cap14.303M
  • Shares Out1.54M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta1.80
  • YTD % Change54.22

RATIOS/PROFITABILITY

  • EPS (TTM)-227.33
  • P/E (TTM)-0.04
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-10.014M
  • ROE (TTM)-348.48%
  • Revenue (TTM)1.817M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-640.91%
  • Debt To Equity (MRQ)30.06%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Addex Therapeutics Ltd

 

Profile

MORE
Addex Therapeutics Ltd is a Switzerland-based clinical-stage pharmaceutical company. The Company focuses on development and commercialization of orally available small molecule drugs known as allosteric modulators for neurological disorders. The Company’s clinical programs pipeline include dipraglurant (mGlu5 NAM), which is Phase 2a placebo-controlled clinical trial for Parkinson's disease levodopa-induced dyskinesia (PD-LID), and is being prepared to enter registration...
Vincent Lawton
Independent Non-Executive Chairman of the Board of Directors
Tim Dyer
Chief Executive Officer, Co-Founder, Member of the Executive Management, Director
Address
Chemin des Mines, 9
Plan-les-ouates
1202
Switzerland